Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 5MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
Sector
Industry
History
$ 7.67Close
$ 4.25 - $ 27.58 52-Week Range
Ticker Information
Ticker
LYRACompany Name
LYRA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLYRA THERAPEUTICS INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LYRA - CF - Equity Historical data
| Date | Net Cash Flow - Issuance (Purchase) of Equity Shares |
|---|---|
| 6/30/2025 | $ 5M |
| 3/31/2025 | $ 8K |
| 12/31/2024 | $ 8.82M |
| 9/30/2024 | $ 28.06M |
| 6/30/2024 | $ 28.07M |
| 3/31/2024 | $ 78.15M |
| 12/31/2023 | $ 69.34M |
| 9/30/2023 | $ 50.1M |
| 6/30/2023 | $ 50.1M |
| 3/31/2023 | $ 100.5M |
Key Performance Insights, Last 5 Years
- LYRA THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Equity stands at $ 57.52M.
- Over the past 5 years, LYRA THERAPEUTICS INC's average CF - Equity has been $ 44.02M.
- The median CF - Equity for LYRA THERAPEUTICS INC during this period was $ 50.1M
- LYRA THERAPEUTICS INC reached its highest CF - Equity over the past 5 years at $ 100.51M.
- The lowest CF - Equity recorded by LYRA THERAPEUTICS INC in the same timeframe $ -74K
LYRA THERAPEUTICS INC's CF - Equity vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Equity Benchmarks
Similar metrics to CF - Equity:
- Net Cash Flow - Issuance (Repayment) of Debt Securities - [Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from issuance (repayment) of debt.
- Net Cash Flow - Financing - [Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.
- Net Cash Flow - Dividends & Other Cash Distributions - [Cash Flow Statement] A component of cash flow from financing [NCFF], representing dividends and dividend equivalents paid on common stock and restricted stock units.
- Buyback Yield - [Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
- Net Cash Flow - Business Acquisitions and Disposals - [Cash Flow Statement] A component of cash flow from investing [NCFI], representing the net amount of cash to acquire (outflow) or dispose (inflow) businesses, join-ventures, affiliates or other investments.
Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares
[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).LYRA - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years
$ -74K
Minimum
Jun 30, 2021
$ 100.51M
Maximum
Jun 30, 2022
$ 44.02M
Average
$ 50.1M
Median
CF - Equity Benchmark AnalysisMarket
The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 107.22K with a standard deviation of $ 17.65M.
The following table provides additional summary stats:
CF - Equity in the Market:
| filtered constituents | 2.89K |
|---|---|
| min | $ -60.59M |
| max | $ 60.64M |
| average | $ 107.22K |
| median | $ 0 |
| std | $ 17.65M |